Quantitative language features identify placebo responders in chronic back pain

Area of Science:

• Psychology
• Neuroscience
• Medical Humanities

Background:

• Increasing placebo effect sizes in chronic pain clinical trials necessitate reliable prediction methods.
• Understanding individual psychological factors influencing placebo responses is crucial for treatment optimization.
• Language analysis offers a novel avenue for investigating cognitive and emotional processes in placebo effects.

Purpose of the Study:

• To determine if patients' language characteristics can predict placebo pill responses in chronic back pain.
• To quantify placebo responses using semantic and psycholinguistic features from patient speech.
• To explore the association between language features, psychological traits, and placebo analgesia.

Main Methods:

• Collected speech content from patients in a placebo analgesia clinical trial (62 patients).
• Quantified over 300 semantic and psycholinguistic features from exit interview transcripts.
• Employed a nested leave-one-out cross-validation approach to distinguish placebo responders from nonresponders.

Main Results:

• Language features alone distinguished placebo responders from nonresponders with 79% accuracy.
• Specific features, including semantic distances to identity/stigma and achievement-related words, explained 46% of placebo analgesia variance.
• Language features predicted placebo response independently of generic treatment effects and personality traits, explaining an additional 31% of variance.

Conclusions:

• Patients' language is sufficient to identify placebo responses in chronic pain.
• Specific speech patterns, related to emotional expression and awareness, differentiate placebo responders.
• Language analysis holds potential for predicting placebo responsiveness and understanding individual treatment experiences.